试验撤回ClinicalTrials.gov(美国登记平台)来源日期:2018-10-17
Comparing the Quality of Life of Terminal Ileitis Patients With Crohn's Disease Treated With Anti-TNF or Surgical Resection
编号:NCT02872506登记状态:入组前撤回企业 / 申办者:University Hospital, Lille
药物 / 成分:Anti TNF、ileocecal resection
登记的停止原因(原文):investigator decision
查看官方原始记录 ↗试验撤回ClinicalTrials.gov(美国登记平台)来源日期:2018-10-16
CSL H1N1 Influenza Vaccine Administered at Different Dose Levels With and Without AS03 Adjuvant in Healthy Adult and Elderly Populations
编号:NCT00964951登记状态:入组前撤回企业 / 申办者:National Institute of Allergy and Infectious Diseases (NIAID)
药物 / 成分:AS03、Inactivated H1N1 Vaccine
查看官方原始记录 ↗试验撤回ClinicalTrials.gov(美国登记平台)来源日期:2018-10-16
Autoimmune Diabetes Accelerator Prevention Trial
编号:NCT02881528登记状态:入组前撤回企业 / 申办者:University of Exeter
药物 / 成分:Metformin Hydrochloride、Placebo
登记的停止原因(原文):Poor Recruitment prior to end of funding timelines.
查看官方原始记录 ↗试验撤回ClinicalTrials.gov(美国登记平台)来源日期:2018-10-16
Does Liposomal Bupivacaine Provide Improved Pain Management for ORIF of Midshaft Clavicle Fractures?
编号:NCT03020563登记状态:入组前撤回企业 / 申办者:University of Minnesota
药物 / 成分:Liposomal Bupivacaine、Bupivacaine
登记的停止原因(原文):no longer necessary
查看官方原始记录 ↗试验撤回ClinicalTrials.gov(美国登记平台)来源日期:2018-10-16
A Safety and Efficacy Study of Intranasal GSK2245035 in Adults With Allergic Asthma
编号:NCT03707678登记状态:入组前撤回企业 / 申办者:GlaxoSmithKline
药物 / 成分:GSK2245035、Placebo、FP-DPI、Albuterol/Salbutamol
登记的停止原因(原文):After careful review of new data on GSK2245035, GlaxoSmithKline has decided to cancel this study.
查看官方原始记录 ↗试验撤回ClinicalTrials.gov(美国登记平台)来源日期:2018-10-15
Fluoxetine Prevention Trial
编号:NCT01615055登记状态:入组前撤回企业 / 申办者:University of California, Los Angeles
药物 / 成分:Fluoxetine、Placebo
登记的停止原因(原文):Study withdrawn. No participants enrolled.
查看官方原始记录 ↗试验撤回ClinicalTrials.gov(美国登记平台)来源日期:2018-10-15
A Study of SBRT in Combination With rhGM-CSF for Stage IV NSCLC Patients Who Failed in Second-line Chemotherapy
编号:NCT02623595登记状态:入组前撤回企业 / 申办者:Wuhan University
药物 / 成分:Stereotactic body radiotherapy、rhGM-CSF
登记的停止原因(原文):Patient enrollment was hard mainly due to we need at least three lesions suitable for SBRT
查看官方原始记录 ↗试验撤回ClinicalTrials.gov(美国登记平台)来源日期:2018-10-15
A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of the GlaxoSmithKline (GSK) Biologicals' Respiratory Syncytial Virus (RSV) Investigational Vaccine (GSK3003891A) in Healthy Pregnant Women and Infants Born to Vaccinated Mothers
编号:NCT03191383登记状态:入组前撤回企业 / 申办者:GlaxoSmithKline
药物 / 成分:RSV vaccine (GSK3003891A) formulation 1、RSV vaccine (GSK3003891A) formulation 2、RSV vaccine (GSK3003891A) formulation 3、Placebo (Formulation buffer S9b)
登记的停止原因(原文):Study was canceled due to instability of the PreF antigen during manufacturing. No safety concern has been identified in past or ongoing studies.
查看官方原始记录 ↗试验撤回ClinicalTrials.gov(美国登记平台)来源日期:2018-10-12
Pre-Emptive Analgesia in Dental Implant Surgery
编号:NCT03243032登记状态:入组前撤回企业 / 申办者:Satheesh Elangovan
药物 / 成分:Ibuprofen 600 mg、Local anesthetic Group 1、Placebo oral capsule、Local anesthetic Control
登记的停止原因(原文):IRB requirements to start study could not be met in a timely manner
查看官方原始记录 ↗试验撤回ClinicalTrials.gov(美国登记平台)来源日期:2018-10-11
Comparing ARNI With ACE Inhibitor on Endothelial Function
编号:NCT03119623登记状态:入组前撤回企业 / 申办者:Brigham and Women's Hospital
药物 / 成分:sacubitril/valsartan、Enalapril
登记的停止原因(原文):Lost funding prior to study commencing
查看官方原始记录 ↗